Cardium Completes $6.0 Million Registered Direct Offering (PR Newswire)
Cardium Therapeutics today announced that it has completed its previously announced $6.0 million registered direct offering of common stock to selected investors.
 

More

  • ENERGY XXI GOM, LLC (form EFFECT)

    ENERGY XXI GOM, LLC Files SEC form EFFECT, Effectiveness Order

  • ACCENTIA BIOPHARMACEUTICALS INC (form EFFECT)

    ACCENTIA BIOPHARMACEUTICALS INC Files SEC form EFFECT, Effectiveness Order